 In September 2011, IBM and WellPoint, a major American healthcare provider, announced a partnership to utilize Watson's data crunching capability to help suggest treatment options to physicians. Then, in February 2013, IBM and WellPoint gave Watson its first commercial application, for utilization management decisions in lung cancer treatment at Memorial Sloan – Kettering Cancer Center.
